These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19537063)

  • 41. Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.
    Yuan H; Chen X; Liu L; Yang L; Pu C; Li J; Bai Y; Han P; Wei Q
    Urol Oncol; 2014 Oct; 32(7):989-1002. PubMed ID: 25082191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
    Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract.
    Novara G; De Marco V; Dalpiaz O; Gottardo F; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V
    BJU Int; 2008 Jun; 101(11):1368-74. PubMed ID: 18241252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
    Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
    Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Large series of 114 cases with long-term follow-up of upper urinary tract urothelial tumors].
    Izquierdo L; Truán D; Alvarez-Vijande R; Alcaraz A
    Actas Urol Esp; 2010 Mar; 34(3):232-7. PubMed ID: 20416239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic factors for upper urinary tract urothelial carcinomas: stage, grade, and smoking status.
    Simsir A; Sarsik B; Cureklibatir I; Sen S; Gunaydin G; Cal C
    Int Urol Nephrol; 2011 Dec; 43(4):1039-45. PubMed ID: 21547471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
    Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
    J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic factors for vesical relapse in patients with upper urothelium tumours treated with surgery.
    Aragón Chamizo J; Herranz Amo F; Hernández Fernández C; González Enguita C
    Actas Urol Esp; 2017 Nov; 41(9):571-576. PubMed ID: 28258788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma.
    Zhang XK; Zhang ZL; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
    Jpn J Clin Oncol; 2015 Nov; 45(11):1069-75. PubMed ID: 26355163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Bladder neoplasm after nephroureterectomy for upper urinary tract tumor. Does distal ureter surgery influx on the evolution?].
    Blanco Díez A; Armas Molina J; Limiñana Cañal JM; Artíles Hernández JL; Martín Betancor D; Chesa Ponce N
    Actas Urol Esp; 2007 Jan; 31(1):23-8. PubMed ID: 17410982
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retroperitoneal laparoscopic nephroureterectomy with bladder cuff excision for native upper tract transitional cell carcinoma ipsilateral to a transplanted kidney.
    Ye J; Ma L; Huang Y; Hou X; Xiao C; Zhao L; Wang G; Hong K; Lu J
    Urology; 2010 Dec; 76(6):1395-9. PubMed ID: 20430425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract.
    Ku JH; Choi WS; Kwak C; Kim HH
    Urol Oncol; 2011; 29(4):383-7. PubMed ID: 19556154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravesical recurrence after surgical management of urothelial carcinoma of the upper urinary tract.
    Hirano D; Okada Y; Nagane Y; Satoh K; Mochida J; Yamanaka Y; Hirakata H; Yamaguchi K; Kawata N; Takahashi S; Henmi A
    Urol Int; 2012; 89(1):71-7. PubMed ID: 22677699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival.
    Colin P; Ouzzane A; Yates DR; Audenet F; Pignot G; Arvin-Berod A; Merigot de Treigny O; Laurent G; Valeri A; Irani J; Saint F; Gardic S; Gres P; Rozet F; Neuzillet Y; Ruffion A; Rouprêt M
    Ann Surg Oncol; 2012 Oct; 19(11):3613-20. PubMed ID: 22843187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Management of the bladder cuff removal by open excision versus transurethral resection of the ureteral orifice after laparoscopic radical nephroureterectomy in upper urinary tract--urothelial carcinoma].
    Tibi B; Quintens H; Carpentier X; Albano L; Durand M; Amiel J
    Prog Urol; 2014 Feb; 24(2):94-101. PubMed ID: 24485078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Yonsei Med J; 2015 Mar; 56(2):375-81. PubMed ID: 25683984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bladder tumor recurrence after primary surgery for transitional cell carcinoma of the upper urinary tract.
    Oehlschläger S; Baldauf A; Wiessner D; Gellrich J; Hakenberg OW; Wirth MP
    Urol Int; 2004; 73(3):209-11. PubMed ID: 15539838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bladder neoplasms after nephroureterectomy: does the surgery of the lower ureter, transurethral resection or open surgery, influence the evolution?
    Salvador-Bayarri J; Rodríguez-Villamil L; Imperatore V; Palou Redorta J; Villavicencio-Mavrich H; Vicente-Rodríguez J
    Eur Urol; 2002 Jan; 41(1):30-3. PubMed ID: 11999462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biological Behavior and Long-Term Outcomes of Carcinoma In Situ in Upper Urinary Tract Managed by Radical Nephroureterectomy.
    Inamoto T; Matsuyama H; Ibuki N; Komura K; Takahara K; Fujimoto K; Shiina H; Sakano S; Nagao K; Miyake M; Tatsumi Y; Yasumoto H; Azuma H;
    J Urol; 2018 Apr; 199(4):933-939. PubMed ID: 29037861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.